Recruiting
NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
NCT06651151
- Conditions
- Melanoma, Melanoma Stage IIIB-IV, Neoplasms, +10 more
- Locations
-
- Oslo University Hospital Oslo, Norway